NCT00804206 Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation Status TERMINATED Phase PHASE4
NCT00803062 Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Status COMPLETED Phase PHASE3
NCT00802906 Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) Status COMPLETED Phase NA
NCT00800917 A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00798603 Pemetrexed, Carboplatin, and Bevacizumab as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00797485 Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE3
NCT00795665 Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma Status COMPLETED Phase PHASE2
NCT00786669 A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors Status COMPLETED Phase PHASE1
NCT00786643 Study of Gamma Interfereon in Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT00785291 Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Status COMPLETED Phase PHASE3
NCT00782275 Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT00781846 Trial of Deforolimus in Combination With Bevacizumab for Patients With Advanced Cancers (8669-010)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00780494 Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma Status COMPLETED Phase PHASE2
NCT00779311 A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1
NCT00776594 Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy Status COMPLETED Phase PHASE2
NCT00773695 A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00762255 A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma Status COMPLETED Phase PHASE1